Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 5

Results: 23

Haematological changes from conception to childbirth: An indicator of major pregnancy complications.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 566, doi. 10.1111/ejh.13844

By:

Patxot, Marion;
Stojanov, Miloš;
Ojavee, Sven Erik;
Gobert, Rosanna Pescini;
Kutalik, Zoltán;
Gavillet, Mathilde;
Baud, David;
Robinson, Matthew R.

Publication type:

Article

Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 576, doi. 10.1111/ejh.13845

By:

Larsen, Morten K.;
Skov, Vibe;
Kjær, Lasse;
Møller‐Palacino, Natascha A.;
Pedersen, Rasmus K.;
Andersen, Morten;
Ottesen, Johnny T.;
Cordua, Sabrina;
Poulsen, Henrik E.;
Dahl, Morten;
Knudsen, Trine A.;
Eickhardt‐Dalbøge, Christina Schjellerup;
Koschmieder, Steffen;
Pedersen, Kasper M.;
Çolak, Yunus;
Bojesen, Stig E.;
Nordestgaard, Børge G.;
Stiehl, Thomas;
Hasselbalch, Hans C.;
Ellervik, Christina

Publication type:

Article

Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: A retrospective study.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 494, doi. 10.1111/ejh.13834

By:

Al‐Ansari, Ameena Mohammed;
Abd‐El‐Gawad, Wafaa Mostafa;
AboSerea, Sobhi Mostafa;
Ali, Ali Adli;
Abdullah, Maha Mohammed;
Ali, Fatma Abdel Shakor;
ElShereafy, Eman El Sayed;
Bahnasy, Mohamed Abd El Badie

Publication type:

Article

Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 483, doi. 10.1111/ejh.13833

By:

Giudice, Valentina;
Serio, Bianca;
Bertolini, Angela;
Mettivier, Laura;
D'Alto, Francesca;
Pezzullo, Luca;
D'Addona, Matteo;
Fumo, Rosalba;
Zeppa, Pio;
Gorrese, Marisa;
Selleri, Carmine

Publication type:

Article

Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 526, doi. 10.1111/ejh.13841

By:

Christensen, Sarah Friis;
Svingel, Lise Skovgaard;
Kjærsgaard, Anders;
Stenling, Anna;
Darvalics, Bianka;
Paulsson, Björn;
Andersen, Christen Lykkegaard;
Christiansen, Christian Fynbo;
Stentoft, Jesper;
Starklint, Jørn;
Severinsen, Marianne Tang;
Clausen, Mette Borg;
Hilsøe, Morten Hagemann;
Hasselbalch, Hans Carl;
Frederiksen, Henrik;
Mikkelsen, Ellen Margrethe;
Bak, Marie

Publication type:

Article

Palliative care utilization, transfusion burden, and end‐of‐life care for patients with multiple myeloma.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 559, doi. 10.1111/ejh.13843

By:

McInturf, Geoffrey;
Younger, Kimberly;
Sanchez, Courtney;
Walde, Charles;
Abdallah, Al‐Ola;
Ahmed, Nausheen;
Shune, Leyla;
Sborov, Douglas W.;
Godara, Amandeep;
McClune, Brian;
Sinclair, Christian T.;
Mohyuddin, Ghulam Rehman

Publication type:

Article

Idiopathic upper extremity deep vein thrombosis: A systematic review.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 542, doi. 10.1111/ejh.13842

By:

Yuen, Hiu Lam Agnes;
Tan, Ee;
Tran, Huyen;
Chunilal, Sanjeev Daya

Publication type:

Article

Treatment horizon in multiple myeloma.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 425, doi. 10.1111/ejh.13840

By:

Soekojo, Cinnie Yentia;
Chng, Wee Joo

Publication type:

Article

The evolution of immune dysfunction in multiple myeloma.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 415, doi. 10.1111/ejh.13839

By:

Soekojo, Cinnie Yentia;
Chng, Wee Joo

Publication type:

Article

Association of iron infusion reactions with ABO blood type.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 519, doi. 10.1111/ejh.13838

By:

Butt, Ayesha;
Muradashvili, Tinatin;
Soliman, Sara;
Li, Fangyong;
Burns, Adrienne J.;
Brooks, Andrea;
Browning, Sabrina;
Bar, Noffar;
Borgman, Gena;
Goshua, George;
Hwa, John;
Martin, Kelsey;
Rinder, Henry;
Tormey, Christopher;
Pine, Alexander B.;
Bona, Robert D.;
Lee, Alfred I.;
Neparidze, Natalia

Publication type:

Article

Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 504, doi. 10.1111/ejh.13835

By:

Spicka, Ivan;
Moreau, Philippe;
Martin, Thomas G.;
Facon, Thierry;
Martinez, Gracia;
Oriol, Albert;
Koh, Youngil;
Lim, Andrew;
Mikala, Gabor;
Rosiñol, Laura;
Yağci, Münci;
Cavo, Michele;
Risse, Marie‐Laure;
Asset, Gaëlle;
Macé, Sandrine;
van de Velde, Helgi;
Yong, Kwee

Publication type:

Article

Loss of LEF‐1 expression as a diagnostic indicator for extranodal NK/T‐cell lymphoma: An immunohistochemical study of 88 cases.

Published in:

2022

By:

Qiu, Cen;
Du, Guangye

Publication type:

Case Study

Venetoclax induces deep and durable minimal residual disease‐negative remission in high‐risk TP53 disrupted B prolymphocytic leukaemia.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 590, doi. 10.1111/ejh.13837

By:

Chen, Lucia Y.;
Eyre, Toby A.

Publication type:

Article

Risk of multiple myeloma and other malignancies among first‐and second‐degree relatives of patients with multiple myeloma: A population‐based study.

Published in:: 2022
Publication type:: Correction Notice

Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the "RTL" (Regional TUSCAN Lymphoma Network)—Authors' reply to Morris and colleagues.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 595, doi. 10.1111/ejh.13831

By:

Cencini, Emanuele;
Fabbri, Alberto

Publication type:

Article

Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe.

Published in:

2022

By:

Ferlis, Mica;
Lipato, Thokozeni;
Roseff, Susan D.;
Smith, Wally R.

Publication type:

Case Study

Pixantrone as a bridge to CAR‐T treatment in high‐grade transformation of follicular lymphoma.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 593, doi. 10.1111/ejh.13829

By:

Morris, Joseph;
O'Reilly, Maeve;
Sargent, Jeremy;
Murphy, Philip;
Glavey, Siobhan;
Quinn, John

Publication type:

Article

A retrospective study of treosulfan versus busulfan‐based conditioning in pediatric patients.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 474, doi. 10.1111/ejh.13828

By:

Olivas‐Mazón, Raquel;
Bueno, David;
Sisinni, Luisa;
Mozo, Yasmina;
Casado‐Abad, Gema;
Martínez, Antonio Pérez

Publication type:

Article

Ten‐year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 465, doi. 10.1111/ejh.13827

By:

Phan, Vivian;
Park, Ju Ae;
Dulman, Robin;
Lewis, Angela;
Briere, Noravy;
Notarangelo, Bailey;
Yang, Elizabeth

Publication type:

Article

Neutralizing antibody responses against SARS‐CoV‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 458, doi. 10.1111/ejh.13826

By:

Abdallah, Al‐Ola;
Mahmoudjafari, Zahra;
Atieh, Tahani;
Ahmed, Nausheen;
Cui, Wei;
Shune, Leyla;
Mohan, Meera;
McGuirk, Joseph;
Remker, Cassie;
Foss, Margaret;
Karloff, Ellie;
Fitch, Heather;
Atrash, Shebli

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2022, v. 109, n. 5, p. 413, doi. 10.1111/ejh.13661
Publication type:: Article

Busulfan and cyclophosphamide‐based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion‐dependent thalassemia, even in high risk.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 447, doi. 10.1111/ejh.13825

By:

Mehta, Pallavi;
Kapoor, Jyotsna;
Singh, Aakanksha;
Yadav, Neha;
Singh, Reema;
Halder, Rohan;
Verma, Megha;
Agrawal, Narendra;
Ahmed, Rayaz;
Bhurani, Dinesh

Publication type:

Article

Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals.

Published in:

European Journal of Haematology, 2022, v. 109, n. 5, p. 441, doi. 10.1111/ejh.13824

By:

Elizabeth, Smyth;
Aidan, Kelly;
David, O' Brien;
Deirdre, Waldron;
Sarah, Brophy;
Emer, Atkinson;
Kanthi, Perera;
Crotty, Gerard M.;
Aileen, Walsh;
Michelle, Connolly;
Ruth, Clifford;
Hilary, O'Leary;
Ashique, Khan;
Bacon, Christopher L.;
Emily, Smyth;
McElligott, Anthony M.;
Fiona, Quinn;
Elisabeth, Vandenberghe;
Carmel, Waldron

Publication type:

Article